Forte Accounts Payable vs Short Term Investments Analysis

FBRX Stock  USD 9.10  0.20  2.15%   
Forte Biosciences financial indicator trend analysis is much more than just examining Forte Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Forte Biosciences is a good investment. Please check the relationship between Forte Biosciences Accounts Payable and its Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Accounts Payable vs Short Term Investments

Accounts Payable vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Forte Biosciences Accounts Payable account and Short Term Investments. At this time, the significance of the direction appears to have weak relationship.
The correlation between Forte Biosciences' Accounts Payable and Short Term Investments is 0.34. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Forte Biosciences, assuming nothing else is changed. The correlation between historical values of Forte Biosciences' Accounts Payable and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Forte Biosciences are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Accounts Payable i.e., Forte Biosciences' Accounts Payable and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.34
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents Forte Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Forte Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Term Investments

Short Term Investments is an item under the current assets section of Forte Biosciences balance sheet. It contains any investments Forte Biosciences undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Forte Biosciences can easily liquidate in the marketplace.
Most indicators from Forte Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.Issuance Of Capital Stock is likely to rise to about 23.4 M in 2025, whereas Selling General Administrative is likely to drop slightly above 7.6 M in 2025.
 2023 2024 2025 (projected)
Depreciation And Amortization9K8.1K7.7K
Interest Income1.1M1.3M1.3M

Forte Biosciences fundamental ratios Correlations

0.550.570.650.810.71-0.06-0.640.580.340.710.040.36-0.421.00.9-0.230.84-0.420.48-0.20.820.710.620.711.0
0.550.80.610.020.680.6-0.470.57-0.30.90.730.88-0.360.520.310.30.7-0.360.9-0.660.550.650.920.680.52
0.570.80.930.120.780.35-0.740.74-0.070.850.410.63-0.470.540.250.180.49-0.470.6-0.330.640.720.820.780.54
0.650.610.930.30.760.2-0.770.760.060.710.150.43-0.60.630.350.130.51-0.60.44-0.170.70.650.730.760.64
0.810.020.120.30.34-0.49-0.530.240.60.24-0.42-0.16-0.20.830.88-0.620.51-0.2-0.080.170.620.460.050.340.82
0.710.680.780.760.340.06-0.710.970.240.880.160.34-0.070.690.540.20.5-0.070.630.060.530.750.771.00.69
-0.060.60.350.2-0.490.06-0.050.04-0.930.280.630.75-0.4-0.09-0.180.740.41-0.40.64-0.770.240.210.580.06-0.08
-0.64-0.47-0.74-0.77-0.53-0.71-0.05-0.68-0.1-0.590.18-0.180.26-0.63-0.560.09-0.440.26-0.2-0.05-0.69-0.87-0.45-0.71-0.63
0.580.570.740.760.240.970.04-0.680.220.770.080.21-0.030.560.390.30.34-0.030.520.180.450.660.690.970.56
0.34-0.3-0.070.060.60.24-0.93-0.10.220.06-0.43-0.50.280.360.37-0.71-0.160.28-0.340.64-0.030.01-0.250.240.35
0.710.90.850.710.240.880.28-0.590.770.060.550.7-0.190.680.470.140.64-0.190.82-0.340.630.760.90.870.68
0.040.730.410.15-0.420.160.630.180.08-0.430.550.85-0.20.01-0.230.330.31-0.20.75-0.760.150.060.620.160.02
0.360.880.630.43-0.160.340.75-0.180.21-0.50.70.85-0.460.330.130.320.67-0.460.85-0.880.50.450.820.340.34
-0.42-0.36-0.47-0.6-0.2-0.07-0.40.26-0.030.28-0.19-0.2-0.46-0.42-0.17-0.05-0.591.0-0.240.61-0.56-0.14-0.42-0.07-0.42
1.00.520.540.630.830.69-0.09-0.630.560.360.680.010.33-0.420.91-0.250.83-0.420.46-0.180.820.690.590.691.0
0.90.310.250.350.880.54-0.18-0.560.390.370.47-0.230.13-0.170.91-0.30.76-0.170.29-0.030.670.680.360.540.91
-0.230.30.180.13-0.620.20.740.090.3-0.710.140.330.32-0.05-0.25-0.30.08-0.050.51-0.24-0.070.020.460.2-0.25
0.840.70.490.510.510.50.41-0.440.34-0.160.640.310.67-0.590.830.760.08-0.590.71-0.630.770.620.740.50.84
-0.42-0.36-0.47-0.6-0.2-0.07-0.40.26-0.030.28-0.19-0.2-0.461.0-0.42-0.17-0.05-0.59-0.240.61-0.56-0.14-0.42-0.07-0.42
0.480.90.60.44-0.080.630.64-0.20.52-0.340.820.750.85-0.240.460.290.510.71-0.24-0.640.420.50.930.630.46
-0.2-0.66-0.33-0.170.170.06-0.77-0.050.180.64-0.34-0.76-0.880.61-0.18-0.03-0.24-0.630.61-0.64-0.37-0.16-0.550.06-0.19
0.820.550.640.70.620.530.24-0.690.45-0.030.630.150.5-0.560.820.67-0.070.77-0.560.42-0.370.720.610.530.82
0.710.650.720.650.460.750.21-0.870.660.010.760.060.45-0.140.690.680.020.62-0.140.5-0.160.720.640.750.69
0.620.920.820.730.050.770.58-0.450.69-0.250.90.620.82-0.420.590.360.460.74-0.420.93-0.550.610.640.770.6
0.710.680.780.760.341.00.06-0.710.970.240.870.160.34-0.070.690.540.20.5-0.070.630.060.530.750.770.69
1.00.520.540.640.820.69-0.08-0.630.560.350.680.020.34-0.421.00.91-0.250.84-0.420.46-0.190.820.690.60.69
Click cells to compare fundamentals

Forte Biosciences Account Relationship Matchups

Forte Biosciences fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets61.2M43.3M42.0M39.0M35.1M43.2M
Other Current Liab1.0M812K2.0M2.2M2.0M4.0M
Total Current Liabilities2.3M1.8M3.2M3.7M3.3M6.0M
Total Stockholder Equity59.0M41.5M38.8M35.3M40.6M42.2M
Property Plant And Equipment Net150.6K97K0.0109K98.1K93.2K
Net Debt(58.8M)(42.0M)(41.1M)(12.0M)(10.8M)(11.3M)
Retained Earnings(51.5M)(73.2M)(87.0M)(118.5M)(136.3M)(143.1M)
Accounts Payable1.2M946K1.2M1.4M1.3M1.3M
Cash58.8M42.0M41.1M12.0M13.8M13.1M
Non Current Assets Total1.3M786K486K653K587.7K558.3K
Cash And Short Term Investments58.8M42.0M41.1M37.1M33.4M41.0M
Common Stock Shares Outstanding294.4K558.7K695.3K1.3M1.1M862.0K
Liabilities And Stockholders Equity61.2M43.3M42.0M39.0M35.1M43.2M
Non Current Liabilities Total28.4M10.5M1.2M946K1.2M0.0
Other Current Assets1.1M476K411K1.2M1.1M831.3K
Other Stockholder Equity49.2M71.4M125.8M153.8M138.4M96.1M
Total Liab2.3M1.8M3.2M3.7M3.3M3.1M
Property Plant And Equipment Gross150.6K97K0.0118K106.2K100.9K
Total Current Assets59.9M42.5M41.5M38.3M34.5M41.8M
Accumulated Other Comprehensive Income10K(61.2M)(43.3M)4K3.6K3.8K
Net Tangible Assets(4.8M)59.0M41.5M38.8M44.6M29.4M
Net Invested Capital59.0M41.5M38.8M35.3M40.6M37.4M
Capital Stock13K15K21K36K41.4K43.5K
Net Working Capital57.6M40.8M38.3M34.7M39.9M38.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.